Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 6.81 USD 1.19% Market Closed
Market Cap: 392.8m USD

Kamada Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kamada Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Operating Income
$27.8m
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
N/A
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Operating Income
-$14.6m
CAGR 3-Years
17%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
Urogen Pharma Ltd
NASDAQ:URGN
Operating Income
-$133.4m
CAGR 3-Years
-19%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Operating Income
-$10.8m
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Operating Income
-$23.3m
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
1%
M
Matricelf Ltd
TASE:MTLF
Operating Income
-₪16.1m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kamada Ltd
Glance View

Market Cap
392.8m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
HIDDEN
Show

See Also

What is Kamada Ltd's Operating Income?
Operating Income
27.8m USD

Based on the financial report for Sep 30, 2025, Kamada Ltd's Operating Income amounts to 27.8m USD.

What is Kamada Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
5%

Over the last year, the Operating Income growth was 56%.

Back to Top